Mpac Group Plc · LSE:MPAC

Mpac — FY2015 Earnings Presentation

22 slides from Mpac's earnings presentation, Feb 25, 2016

  1. Slide 1: Preliminary Full Year Results

    Preliminary Full Year Results Year to 31 December 2015

  2. Slide 2: The Business

    The Business 2015 sales by n Well-established international specialist technology and services group division – high performance instrumentation, machinery and aftermarket services – market-leading expertise Packaging Instrumentation Machinery & Tobacco – reputation for high service levels Machinery

  3. Slide 3: Results: Operational Key Points

    Results: Operational Key Points n Results in line with management expectations n Disposal of analytical services business completed in May 2015 following strategic review n Instrumentation & Tobacco Machinery division affected by continuing challenging market conditions n Packaging Machinery divisio

  4. Slide 4: Results: Financial Key Points – continuing operations

    Results: Financial Key Points – continuing operations n Sales of £87.0m (2014: £87.4m) n Underlying PBT of £3.8m (2014: £5.3m) n Underlying of EPS of 15.1p (2014: 22.4p) n Loss from discontinued operations of £5.8m (2014: £3.6m) n Net debt of £3.2m (Dec 2014: £2.1m) n Proposed final dividend of 1.5p

  5. Slide 5: Financial Review: Income Statement

    Financial Review: Income Statement 2011 £m 2015 2014 £m £m n Sales within Packaging Machinery up 26% supported Sales 87.0 87.4 by strong opening order book; I&TM sales down by Underlying operating profit* 4.0 5.4 23% arising from continued weak market conditions Non-underlying items (1.1) (1.2) n Si

  6. Slide 6: Financial Review: Cash Flows

    Financial Review: Cash Flows 2015 2014 £m £m Cash flows from operating activities 3.6 (0.5) n Cash flows from operating activities: – £0.4m working capital decrease Cash flows from investing activities (2.7) (4.8) – £1.9m pension deficit payments Cash flows from financing activities (1.5) (1.5) – £0

  7. Slide 7: Financial Review: Balance Sheet

    Financial Review: Balance Sheet 2015 2014 Net assets £m £m Intangible Goodwill 7.4 8.6 n Goodwill at December 2015 relates to Cerulean assets: n Property, plant and equipment includes £0.8m of Product development 7.5 7.1 investment property & other intangibles n Tax balance includes £0.5m (2014: £0.

  8. Slide 8: Divisional Trading Results

    Divisional Trading Results 2015 2014 Sales £m £m Packaging Machinery 51.0 40.5 Instrumentation & Tobacco Machinery 36.0 46.9 Total 87.0 87.4 Underlying operating profit* Packaging Machinery 3.9 1.8 Instrumentation & Tobacco Machinery 0.1 3.6 Total 4.0 5.4 * Before non-underlying items 7 >>

  9. Slide 9: Packaging Machinery: Business Overview

    Packaging Machinery: Business Overview n Leading supplier of complex highly automated product handling, cartoning and robotic end-of-line packaging and processing equipment n Innovative technology tailored for specific niches within the following sectors – nutrition – beverages – healthcare – pharma

  10. Slide 10: Packaging Machinery: Operating Performance

    Packaging Machinery: Operating Performance 2015 2014 Sales £51.0m £40.5m Operating profit £3.9m £1.8m Return on sales 7.6% 4.4% n Sales increased by 26% - supported by strong opening order book at January 2015 – good progress in pharmaceutical and healthcare sectors n Significant improvements in mar

  11. Slide 11: Instrumentation & Tobacco Machinery: Business Overview

    Instrumentation & Tobacco Machinery: Business Overview n Supplier of instrumentation, machinery and aftermarket services, predominantly to the tobacco industry n Global presence – UK, USA, Brazil, Singapore, Czech Republic, Russia, Egypt, India and China n Well developed supply chain, with instrumen

  12. Slide 12: Instrumentation & Tobacco Machinery: Operating Performance

    Instrumentation & Tobacco Machinery: Operating Performance 2015 2014 Sales £36.0m £46.9m Operating profit* £0.1m £3.6m Operating margin* 0.3% 7.7% *Before reorganisation costs of £0.4m (Dec 2014: £0.5m) n Tobacco sector conditions remain tough with continued contraction in capital investment – incre

  13. Slide 13: Outlook

    Outlook n Little sign of an immediate recovery in the tobacco sector, although the order book at the beginning of 2016 for the instrumentation business was strong n More cautious view of trading conditions for the Packaging Machinery division - although there are significant numbers of prospective p

  14. Slide 14: Supplementary Information

    Supplementary Information - Taxation and EPS - Cash Flow - Working Capital - Banking Facilities - Pensions - Discontinued Operations 13

  15. Slide 15: Taxation & EPS

    Taxation & EPS Taxation Earnings per share 2015 2014 2015 2014 £m £m Underlying tax charge 0.9 0.9 Underlying EPS 15.1p 22.4p Tax credit on pension (0.4) (0.1) Profit before non-underlying items £2.9m £4.4m scheme balances Basic loss per share (20.9)p (1.3)p Tax credit on (0.2) (0.2) Loss for the pe

  16. Slide 16: Cash Flow

    Cash Flow 2015 2014 2015 2014 £m £m £m £m Underlying operating profit* 4.0 5.4 Interest received 0.1 0.2 Depreciation & amortisation 2.6 2.4 Capital expenditure (net) (0.9) (1.9) Other non-cash items 0.2 0.1 Development expenditure (1.9) (3.1) Pension payments (ex. reorganisation) (1.9) (1.8) Purcha

  17. Slide 17: Working Capital

    Working Capital 2015 2014 £m £m Inventories decrease/(increase) 2.2 (0.6) Receivables decrease/(increase) 6.4 (1.5) Payables decrease (8.1) (0.7) Provisions decrease (0.1) (0.2) Net working capital decrease/(increase) 0.4 (3.0) 16 >>

  18. Slide 18: Banking Facilities

    Banking Facilities n UK committed borrowing facilities of £13.0m renewed in October 2013, committed to September 2018, secured on the Group’s assets n In addition, ancillary facilities in place to cover Group’s bonding, guarantees and foreign exchange requirements 17 >>

  19. Slide 19: Pensions

    Pensions 2015 2014 £m £m n Accounting valuation of the UK scheme improved mainly due to investment income Value of assets UK 346.9 347.9 in excess of actuarial assumptions and US 14.9 15.4 changes in financial and demographic assumptions Total 361.8 363.3 n Funding of UK scheme at £1.8m (+2.1%) per

  20. Slide 20: Discontinued Operations – Arista Laboratories

    Discontinued Operations – Arista Laboratories 2015 2014 £m £m Loss from trading activities (0.9) (2.0) Proceeds from disposal 0.3 - Costs incurred on disposal (0.4) - Loss on disposal of net assets (3.5) - Impairment of goodwill (1.3) (1.6) Loss on discontinued operations (5.8) (3.6) Net decrease in

  21. Slide 21: Disclaimer

    Disclaimer This presentation is being made only to and directed at: (a) persons who events and circumstances that are beyond the control of Molins, have professional experience in matters relating to investments falling including amongst other things, Molins’ future profitability, within Article 19

  22. Slide 22: Contact details

    Dick Hunter Chief Executive David Cowen Group Finance Director Rockingham Drive Linford Wood East Milton Keynes MK14 6LY Tel: +44 (0)1908 246870 Fax: +44 (0)1908 234224

Mpac Group — FY2015 Earnings Presentation on 6ix